Dr. Reddy’s Laboratories announces the first generic launch , Delayed Release Tablets in the U.S. Market

Dr. Reddy’s Laboratories announces the first generic launch , Delayed Release Tablets in the U.S. Market

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the first-to-market launch of Naproxen and Esomeprazole Magnesium Delayed-Release Tablets, a therapeutic equivalent generic version of Vimovo® (Naproxen and Esomeprazole Magnesium) Delayed-Release Tablets approved by the U.S. Food and Drug Administration (USFDA).“This launch is a testament to our core strengths in areas of research and development and intellectual property,” says Marc Kikuchi, Chief Executive Officer, North America Generics. “We are excited to be a part of forming the first generic market for Vimovo®  Tablets and to provide an affordable treatment alternative for patients.”

The Vimovo® (Naproxen and Esomeprazole Magnesium) Delayed-Release Tablets brand had U.S. sales of approximately $414 million MAT for the most recent twelve months ending in December 2019 according to IQVIA Health*.Dr. Reddy’s Naproxen and Esomeprazole Magnesium Delayed-Release Tablets are available in 375 mg/20 mg and 500 mg/20 mg .Dr. Reddy’s Laboratories announces the first generic launch , Delayed Release Tablets in the U.S. Market

Comments

  1. Good article,Keep posting like this article,it is helpful to us,thank you.
    For best indian astrology services contact us Best Astrologer in Jasper

    ReplyDelete
  2. Such a great post, thanks for posting this kind of useful information
    Visit website for best astrological services contact. Best Astrologer in Chikmagalur

    ReplyDelete
  3. Good astrologycal post for love problem solutions,thank you for sharing with us.
    For sofa repair work contact thesofastore gives Sofa Refurbishing in Indiranagar,Bangalore

    ReplyDelete

Post a Comment

Popular posts from this blog

JCB India launches its new 3DX ecoXPERT